Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients

por Serpero, Laura D., Filaci, Gilberto, Parodi, Alessia, Battaglia, Florinda, Kalli, Francesca, Brogi, Davide, Mancardi, Giovanni Luigi, Uccelli, Antonio, Fenoglio, Daniela
Publicado 2013

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

por Laroni, Alice, Brogi, Davide, Morra, Vincenzo Brescia, Guidi, Leonello, Pozzilli, Carlo, Comi, Giancarlo, Lugaresi, Alessandra, Turrini, Renato, Raimondi, Debora, Uccelli, Antonio, Mancardi, Giovanni Luigi
Publicado 2014